APPLICATION
ANDA209182
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-04
LATEST ACTION
2021-11-12
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
NEOSTIGMINE METHYLSULFATEDiscontinued
NEOSTIGMINE METHYLSULFATE 10MG/10ML (1MG/ML) · SOLUTION · INTRAVENOUS
NEOSTIGMINE METHYLSULFATEDiscontinued
NEOSTIGMINE METHYLSULFATE 5MG/10ML (0.5MG/ML) · SOLUTION · INTRAVENOUS
Approval history
2021-11-12Labeling · Supplement 3 · standardAP
2018-05-04UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.